Vertex Pharmaceuticals (MA), Johnson & Johnson Hepatitis C Drug Works After Others Fail Like Merck & Co., Inc.'s Boceprevir

September 8, 2010 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

Bloomberg -- Vertex Pharmaceuticals Inc.’s most advanced experimental drug, in development with Johnson & Johnson, worked in patients with hepatitis C who didn’t respond to other treatment, a study found.

Twitter
LinkedIn
Facebook
Email
Print

Clinical research Phase III

Johnson & Johnson Family of Companies Merck & Co. Vertex Pharmaceuticals